2008 · 20 citations · 0 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyDiabetologyDisease PreventionCardiovascular Disease PreventionDiabetes MellitusDiabetes PharmacotherapyDiabetes PreventionGlycemic ControlInsulin ResistanceCardiovascular Risk ManagementGlycemic Control TargetsGlycemic TargetsImpaired Glucose ToleranceInsulin Resistance TreatmentMetabolic ToleranceType 2 Diabetes Risk Reduction
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance : rationale and design of the Nateglinide And Valsartan in impaired Glucose Tolerance Outcomes Research (NAVIGATOR)